Skip to main content

Local navigation

James E. Gern, MD

James E. Gern, MD

Professor

Related Links


Contact the Group

(608) 263-6201

UW Hospital
600 Highland Ave - K4/918
Madison, WI 53792-9988


Gern Laboratory


Major Research Interests

The Gern Laboratory Group is conducting several NIH-funded studies to define the role of viral infections in the initiation and disease activity of asthma, and to identify interactions between host and viral factors that determine the severity of respiratory illnesses. Dr. Gern is the Principal Investigator for the University of Wisconsin Asthma and Allergic Diseases Clinical Research Center (AADCRC). This is a collaborative program involving investigators in the Allergy/Immunology Division and basic scientists (Ann Palmenberg, Institute of Molecular Virology; Paul Bertics, Biomolecular Chemistry; Lou Rosenthal, Pediatrics; Wai Ming Lee, Pediatrics) at the University of Wisconsin. The goals of the project are to determine how infections with rhinoviruses cause exacerbations of asthma in children. The AADCRC clinical project is known as RhinoGen, and is a large observational study of 400 children (half with asthma) to identify host and genetic factors that promote more severe rhinovirus illnesses and exacerbations of asthma.

The Gern Laboratory Group is working on two birth cohort studies of asthma. As part of the Childhood Origins of Asthma (COAST) study, we are identifying new strains of rhinoviruses, and determining whether there are specific strains associated with more severe illnesses and acute asthma. In addition, Dr. Gern leads the Urban Environment and Childhood Asthma (URECA) study for the Inner City Asthma Consortium. The goal of this birth cohort study is to identify lifestyle and environmental factors (including viral infections) unique to the urban environment that influence early immune development to increase the risks for allergic diseases and asthma.

Finally, the laboratory is conducting translational research projects to identify virus-induced inflammatory mechanisms involving airway epithelial cells and T regulatory cells, and experimental inoculation studies of volunteers with asthma using a safety-tested strain of rhinovirus.


Staff


No Photo Available

Svetlana P. Amineva

Assistant Scientist

Yury A. Bochkov, PhD

Yury A. Bochkov, PhD

Assistant Researcher

Jack A. Bork

Jack A. Bork

Research Specialist

Rebecca A. Brockman-Schneider

Rebecca A. Brockman-Schneider

Associate Researcher

No Photo Available

Lillian Chen

Graduate Trainee

Amy S. Dresen

Amy S. Dresen

Senior Research Specialist

Heather L. Floerke

Heather L. Floerke

Associate Research Specialist

No Photo Available

Lauren R. George

Student Hourly

No Photo Available

Kristine A. Grindle

Research Specialist

No Photo Available

Kathleen S. Hemauer

Associate Research Specialist

Theresa J. Kang

Theresa J. Kang

Associate Research Specialist

Wai-Ming Lee

Wai-Ming Lee

Senior Scientist

No Photo Available

Guiyan Liu

Visiting Scholar

Tressa E. Pappas

Tressa E. Pappas

Research Specialist

Lisa E. Salazar

Lisa E. Salazar

Research Specialist

No Photo Available

Haley B. Stellmacher

Student Hourly

No Photo Available

Fue Vang

Research Specialist

   

Active Grants

Asthma and Allergic Diseases Clinical Research Center: Mechanisms of Rhinovirus-Induced Exacerbations of Asthma
NIH NIAID U19 AI070503-01
09/01/06–08/31/11

COAST III – Rhinovirus Infection and Childhood Asthma
NIH-NHLBI P01 HL070831 (Lemanske)
5/01/08–03/31/13

NIAID Inner City Asthma Consortium: Immunologic Approaches to Reduced Asthma
RFP/contract #NIH-NIAID-DAIT-02-11 (Busse)
09/30/02-09/29/09

Wisconsin Allergy and Immunology Research, Training Program
NIH-NIAID 2 T32 AI007635-06 (Gern)
10/01/05-9/30/10

T Regulatory Cells and Childhood Asthma
NIH/NIAID R01 HL080072-01 (Gern)
9/01/04–05/31/09

The Effect of ‘Adjustable’ Treatment with Budesonide/Formoterol on Rhinovirus Provoked Exacerbations of Asthma
AstraZeneca Investigator-sponsored Study (Busse)
12/15/08-12/14/10


Honors & Awards

Armed Forces Health Sciences Scholarship 1978
Clinical Allergy Fellowship Award
Allen and Hanburys Respiratory Institute
1992
Gerard B. Odell Research Award
Department of Pediatrics
University of Wisconsin School of Medicine and Public Health
1996
The Dean’s Award for Excellence in Health Care Communication
University of Wisconsin-Madison
1998
Society for Pediatric Research 2001-2009
AAAAI Visiting Professorship
New England Medical Center, Boston, MA. Section on Allergy and Immunology
American Academy of Pediatrics
2002
“Best Doctors in America” 2002-2009
Consumers’ Research Council of America “Guide to America’s Top Pediatricians" 2004
AAAAI Visiting Professorship
Phoenix Children’s Hospital Section on Allergy and Immunology
American Academy of Pediatrics
2002
Alberta Heritage Foundation for Medical Research Visiting Lecturer
University of Alberta and University of Calgary, Canada
2006
Elected to the American Pediatric Society 2006
Riven Visiting Lecturer
Vanderbilt University, Nashville TN
2007
Elliott Middleton Memorial Lecturer
American Academy of Allergy, Asthma and Immunology Annual Meeting
2008

Recent Publications

Jartti T, Burmeister K, Seroogy C, Jennens-Clough ML Tisler C, Salazar L, DaSilva D, Evans M, Vrtis R, Wallace PK, Ruiz-Perez B, Gangnon R, Lemanske RF Jr, Gern JE. Association between CD4+CD25high T cells and atopy in children. J Allergy Clin Immunol. 2007;120(1):177-83.

Lee WM, Kiesner C, Pappas T, Lee I, Grindle K, Jartti T, Jakiela B, Lemanske, RF, Shult PA, Gern JE. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS ONE. 2007;2(10):e966.

Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE. Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection, Am J Respir Cell Mol Biol. 2008;38:517-23.

Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RP, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF Jr, Nicolae DL, Elias JA, Chupp GL. Variation in the CHI3L1 gene influences serum YKL-40 levels, asthma risk, and lung function. NEJM. 2008;358:1682-91.

Gern JE, Stone CK, Nakano M, Muchmore DB, de la Peña A, Park S, Suri A, Tibaldi F, Soon D, Busse WW. Effect of upper respiratory tract infection on AIR® inhaled insulin pharmacokinetics and glucodynamics in healthy subjects. Clin Pharmacol Therapeutics. 2008;83:307-311.

Bufford JD, Reardon CL, Li Z, Roberg KA, Tisler C, Anderson E, DaSilva D, Eggleston PA, Liu A, Milton D, Alwis U, Gangnon R, Lemanske RF Jr, Gern JE. Effects of dog exposure in early childhood on immune development and atopic diseases. Clinical and Experimental Allergy. 2008;38:1635-43.

Jartti T, Lee WM, Pappas T, Evans M, Lemanske RF Jr, Gern JE. Serial viral infections in infants with recurrent respiratory illnesses. European Respiratory Journal. 2008;32(2):314-20.

Jackson DJ, Evans MD, Anderson EL, Salazar L, DaSilva DF, Pappas TE, Roberg KA, Tisler CJ, Gangnon R, Gern JE, Lemanske RF Jr. Wheezing rhinovirus illnesses during early childhood predict the subsequent development of asthma. American Journal of Respiratory and Critical Care Medicine. 2008;178:667-672.

Brockman-Schneider RA, Amineva S, Bulat MV, Gern JE. Serial culture of murine primary airway epithelial cells and ex vivo replication of human rhinoviruses. J Immunol Methods. 2008;339:264-6.

Denlinger LC, Shi L, Guadarrama A, Schell K, Green D, Morrin A, Hogan K, Sorkness RL, Busse WW, Gern JE. Attenuated P2X7 pore function as a risk factor for virus induced loss of asthma control. Am J Respir Crit Care Med. 2009;179:265-270.